RxDoctor Payments Data

Kelly Ownby, MD

Psychiatry · Maryville, TNNPI 1518154566

Payments from drug & device makers

$4,413in general payments, 2019–2025

Across 249 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$722
  • AbbVie$600
  • Otsuka America Pharmaceutical, Inc.$528
  • Johnson & Johnson$395
  • Lundbeck LLC$341
  • Alkermes, Inc.$339
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$4,401100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,413 in reported general payments places this provider in the 80th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$65,451
Medicare patients
78
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate16$55,529
RexultiBrexpiprazole11$38,646
TrintellixVortioxetine Hydrobromide15$11,700
Bupropion XlBupropion Hcl111$4,038
Duloxetine Hcl108$2,705
Buspirone Hcl124$2,333
Lurasidone Hcl25$2,305
Clozapine29$2,049
Aripiprazole49$2,031
Divalproex Sodium ErDivalproex Sodium11$2,020
Trazodone Hcl153$1,963
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$1,960
Venlafaxine Hcl ErVenlafaxine Hcl72$1,728
Desvenlafaxine Succinate ErDesvenlafaxine Succinate30$1,705
Lamotrigine104$1,257

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$395$55,52916 claims
Otsuka America Pharmaceutical, Inc.Rexulti$528$38,64611 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$275$11,70015 claims
Almatica Pharma LLCSertraline Hcl$66$1,20986 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 503 psychiatry providers in Tennessee.

Other psychiatry in Maryville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →